Exact Sciences
Genomic Health’s Oncotype DX Genomic Prostate Score® test provides information to help urologists and clinically low-risk prostate cancer patients choose between active surveillance and immediate treatment. For late-stage prostate cancer, the Oncotype DX® AR-V7 Nucleus Detect™ test identifies AR-V7 status, helping to make the critical treatment decision between AR-targeted therapy and chemotherapy.